Prelude Therapeutics Incorporated (PRLD) vs X4 Pharmaceuticals, Inc. (XFOR)
- Prelude Therapeutics Incorporated PRLD 3.26 −1.81%
- X4 Pharmaceuticals, Inc. XFOR 2.59 −1.89%
Prelude Therapeutics Incorporated and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Prelude Therapeutics Incorporated and X4 Pharmaceuticals, Inc. are of similar size ($265.0M and $261.8M). Prelude Therapeutics Incorporated has the higher net margin (−269.8% vs −568.8%) and the higher return on invested capital (0.00% vs −226.6%). Across the 16 metrics below, Prelude Therapeutics Incorporated leads on 12 and X4 Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | PRLD | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.51% | 65.16% |
| Operating margin | (300.56%) | (554.71%) | 0.00% |
| Net margin | (269.75%) | (568.80%) | 0.00% |
| Free cash flow margin | (148.30%) | (559.95%) | 0.00% |
| Return on equity | (57.73%) | (113.08%) | (56.36%) |
| Return on assets | (39.76%) | (50.32%) | (48.04%) |
| Return on invested capital | 0.00% | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack